General Practice Doctors in Bryant, AR - Medicare Status, Address, Contact

1 General Practice doctors found. Showing 1 - 1

Dr. Chelsea Brown, DVM
General Practice
Medicare: Not Enrolled in Medicare
Practice Location: 6309 Highway 5 N, Bryant, AR 72022
Phone: 501-943-8055 Fax: 501-943-8056

News Archive

Kolltan Pharmaceuticals raises $10M for advancing its therapeutic development pipeline

Kolltan Pharmaceuticals, Inc., a next-generation oncology therapeutics company, announced today that it has raised $10 million in investments and related payments from an affiliate of Celtic Therapeutics Holdings L.P. ("Celtic Therapeutics") and Tichenor Ventures, LLC.

Mums feel they get a serve over preschoolers' eating habits

Fear of being criticised by others may be leading Australian mums to be overly concerned about preschoolers being underweight, a new study has found.

Elusys' Anthim BLA to treat inhalational anthrax accepted for review by the FDA

Elusys Therapeutics, Inc. today announced the U.S. Food and Drug Administration has accepted for filing and review its Biologics License Application for Anthim® (obiltoxaximab) for the treatment and prevention of inhalational anthrax, a top bioterror threat which was submitted on March 20, 2015. Anthim is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government's repository of critical medical supplies for biowarfare preparedness.

Biocryst seeks FDA NDA approval for Peramivir to treat influenza

BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.

Ambry Genetics and SoftGenetics sign agreement for next-generation sequencing projects at Ambry

Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics' NextGENe software for next-generation sequencing projects performed at Ambry.

General Practice Doctors in Bryant, AR Accepting Medicare